Literature DB >> 6135572

Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.

A J Streeter, J A Timbrell.   

Abstract

Hydralazine was metabolized in vitro to a reactive metabolite(s) which bound to microsomal protein. The binding was dependent on mixed function oxidase activity, was proportional to time and microsomal protein concentration, and was not removed by acid washing. The apparent Km was 3.55 X 10(-5) M and the Vmax was 0.342 nmol/mg protein/min. Binding was inhibited by carbon monoxide and required oxygen and enzyme activity. Microsomes from animals pretreated with 3-methylcholanthrene showed a slight but significant increase in covalently bound hydralazine metabolite(s) whereas piperonyl butoxide treatment significantly reduced this binding. Glutathione, cysteine, and N-acetylcysteine all reduced the binding when added to incubations. Therefore, hydralazine is metabolized by the microsomal enzymes to a metabolite(s) capable of reacting covalently with cellular macromolecules.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135572

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

2.  Hydralazine-induced lupus: is there a toxic metabolic pathway?

Authors:  J A Timbrell; V Facchini; S J Harland; R Mansilla-Tinoco
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Free radical-mediated activation of hydrazine derivatives.

Authors:  B Kalyanaraman; B K Sinha
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

Review 4.  Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus.

Authors:  R L Rubin; A Kretz-Rommel
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

5.  Case Study 11: Considerations for Enzyme Mapping Experiments-Interaction Between the Aldehyde Oxidase Inhibitor Hydralazine and Glutathione.

Authors:  Rachel D Crouch; Jessica L Beers; Klarissa D Jackson
Journal:  Methods Mol Biol       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.